Overview

Gender

female

Rachel Winokur leads mergers and acquisitions, strategy, and the development and operations of Healthagen's emerging businesses. Ms. Winokur joined Healthagen from the Carlyle Group, a global private equity firm, where she invested in healthcare companies for Carlyle’s US Growth Equity Fund.

Prior to that role, she was Vice President of Business Development and a corporate officer of Datascope, a publicly-traded medical devices company focused on cardiovascular medicine and critical care that was acquired by Mindray and Gettinge.

Previously, Ms.Winokur spent several years in operations and business development with Bertelsmann, a global media company. She started her career at Goldman Sachs in the mergers and acquisitions and equity capital markets departments.

Ms. Winokur received an MBA from Stanford University’s Graduate School of Business and a BSE with honors in biomedical engineering and electrical engineering from Duke University.